BioLargo Q2 2022 Earnings Results Webcast and Conference Call on Wednesday, August 17, 2022 – 4 PM Eastern Time
August 12, 2022
-
-
1847 Holdings Announces Second Quarter 2022 Financial Results
August 12, 2022
-
Helbiz Expands its Micro-mobility Operations in the Washington, DC Area
August 12, 2022
-
Arcimoto Appoints Jesse Fittipaldi as Interim Chief Executive Officer
August 12, 2022
-
Alpine 4 Holdings Announces Q2 2022 Financial Results with Revenue of $50.9 Million For the First Half of 2022
August 12, 2022
-
OriginClear Installs EveraBOX for Integrated Municipal Water Disinfection
August 12, 2022
-
Temas Announces Filing of Positive Preliminary Economic Assessment for Piskanja Boron Project
August 11, 2022
-
Hisense’s U7H and U8H Series TVs Receive WiSA SoundSend Certification
August 11, 2022
-
The Industry Pioneer Set to Dominate as Plant-Based Skincare Goes Mainstream
August 11, 2022
-
Oncolytics Biotech® Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
August 11, 2022
-
Acasti Pharma Reports First Quarter 2023 Operational Results
August 11, 2022
-
Lexaria Discusses Valuation Metrics for Biotech Industry
August 11, 2022
-
Helbiz to Offer On-Demand Taxi Services to Widen International Intermodal Offering
August 11, 2022
-
Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
August 11, 2022
-
Todos Medical Completes Trial Design for Tollovid(TM) Long COVID Clinical Study in Adults
August 11, 2022
-
American Resources Corporation Commences Planning and Development on Next Two Metallurgical Carbon Mines
August 11, 2022